Oral News and Research

RSS

Periodontal disease develops much earlier than dentists and other health professionals thought

Periodontal disease -- a progressive, eventually painful and disruptive condition in which bacteria attack gums and the hidden roots of teeth -- develops much earlier than dentists and other health professionals thought, a major new study concludes.

20 Sep 2005

Oral contraceptives appear to reduce risk of developing multiple sclerosis

Over a three-year period, the risk of developing multiple sclerosis (MS) was reduced in women taking oral contraceptives, according to a study in the September issue of Archives of Neurology.

19 Sep 2005

Use of antibiotics for acne may increase risk of upper respiratory tract infection

Individuals treated with antibiotics for acne for more than six weeks were more than twice as likely to develop an upper respiratory tract infection within one year as individuals with acne who were not treated with antibiotics, according to an article in the September issue of Archives of Dermatology.

19 Sep 2005

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

These results show that a natural product of vitamin A can have an important role in regulating immunity and, when administered along with PIC, might be a potentially powerful nutritional-immunological assist in vaccination."

12 Sep 2005

Budesonide provides lasting relief for Crohn's disease patients

In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.

12 Sep 2005

Generex Biotechnology granted Canadian patent

Generex Biotechnology Corporation has announced that it has been granted a patent by the Canadian Intellectual Property Office titled "Mixed Micellar Delivery System and Method of Preparation."

12 Sep 2005

Part of largest randomised international trial program ever conducted in atrial fibrillation (AF) discontinued

Study treatments for the ACTIVE W trial of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) program have been discontinued due to a significant difference in efficacy, in favour of the standard oral anticoagulation (OAC) over antiplatelet therapy (clopidogrel plus aspirin).

6 Sep 2005

Generex Biotechnology awarded Australian patent

Generex Biotechnology Corporation today announced that it has been granted a patent by the Australian Patent Office titled "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation."

6 Sep 2005

Domantis successful in patent opposition

Domantis Limited, the human Domain Antibody Therapeutics company, has successfully opposed European patent number EP0656946, leading to a major amendment of the main claim in the patent and a significant narrowing of the scope of 34 of the 41 other claims.

1 Sep 2005

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Mayo Clinic Cancer Center investigators report that combination therapy with lenalidomide (Revlimid) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma. Results of a Phase II clinical trial were published online Aug. 23 in Blood.

1 Sep 2005

Toluidine blue dye reveals oral cancers

A team of Canadian scientists may have discovered a way to use a simple dye as a litmus test to identify abnormal areas of the mouth that may become cancers.

1 Sep 2005

Contraceptive pill controls severe premenstrual disorder

According to a new study, a low dose oral contraceptive works as a treatment for the most severe form of premenstrual syndrome, premenstrual dysphoric disorder (PMDD).

1 Sep 2005

Smokers are significantly less likely to seek dental care than nonsmokers

...according to data from a nationally representative sample of 15,250 American adults. The finding holds true regardless of age, gender, race, ethnicity, socioeconomic status, location and insurance coverage.

1 Sep 2005

People with serious mental illness have higher rates of type 2 diabetes

...yet their knowledge of diabetes was generally poor and significantly lower than people without mental illness, according to a new study.

1 Sep 2005

Low dose oral contraceptive effective in controlling premenstrual disorder

A new study led by researchers at Yale School of Medicine shows for the first time that a low dose oral contraceptive with a unique progestin and dosing regimen is effective in treating symptoms of premenstrual dysphoric disorder (PMDD), the most severe form of premenstrual syndrome.

31 Aug 2005

Emergent Biosolutions' typhoid vaccine achieves positive results in Phase II clinical study

Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.

30 Aug 2005

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Many children who undergo bone marrow transplantation (BMT) as part of cancer treatment already have dental abnormalities that leave them vulnerable to potentially life-threatening bacterial infections, according to investigators at St. Jude Children's Research Hospital. A report on this study appears in the prepublication online edition of Bone Marrow Transplantation.

29 Aug 2005

Compound might defeat African sleeping

One of the most devastating diseases in sub-Saharan Africa almost disappeared in the late 1950s.

26 Aug 2005

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.

24 Aug 2005

Heart healthy habits are good for oral health

Heart healthy habits are good for oral health, too, according to a new study published in the current issue of the Journal of Periodontology, the official publication of the American Academy of Periodontology.

22 Aug 2005

Oral News and Research

Periodontal disease develops much earlier than dentists and other health professionals thought

Oral contraceptives appear to reduce risk of developing multiple sclerosis

Use of antibiotics for acne may increase risk of upper respiratory tract infection

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

Budesonide provides lasting relief for Crohn's disease patients

Generex Biotechnology granted Canadian patent

Part of largest randomised international trial program ever conducted in atrial fibrillation (AF) discontinued

Generex Biotechnology awarded Australian patent

Domantis successful in patent opposition

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Toluidine blue dye reveals oral cancers

Contraceptive pill controls severe premenstrual disorder

Smokers are significantly less likely to seek dental care than nonsmokers

People with serious mental illness have higher rates of type 2 diabetes

Low dose oral contraceptive effective in controlling premenstrual disorder

Emergent Biosolutions' typhoid vaccine achieves positive results in Phase II clinical study

Dental problems caused by radiation, chemotherapy should be treated before a child undergoes immunosuppression as part of bone marrow transplantation therapy

Compound might defeat African sleeping

Disease modifying activity of 2ME2 demonstrated in preclinical rheumatoid arthritis studies

Heart healthy habits are good for oral health

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News